Literature DB >> 143740

Continuous- and semicontinuous-flow blood centrifugation systems: therapeutic applications, with plasma-, platelet, lympha-, and eosinapheresis.

A A Pineda, S M Brzica, H F Taswell.   

Abstract

Blood centrifugation, with a continuous-flow or semicontinuous-flow system, was used in the treatment of 17 patients with various hematologic disorders. Total plasma exchange (TPE) controlled symptoms of hyperviscosity and arrested bleeding in three patients. In two patients, TPE made is possible to perform urgent surgical procedures. It was a very valuable adjuvant in the treatment of one patient with a Factor VIII inhibitor. Eosinapheresis was not of significant value in the therapy of syndromes associated with eosinophilia. Lymphapheresis significantly reduced peripheral lymphocytosis, aiding in the chemotherapeutic control of chronic lymphosarcoma cell leukemia in one patient. It was of questionable value in the maintenance therapy of two patients with Sézary syndrome. Plateletapheresis significantly reduced peripheral platelet count in thrombocytosis, making it possible to minimize the chemotherapeutic dose and permitting urgent surgical procedures in two patients.

Entities:  

Mesh:

Year:  1977        PMID: 143740     DOI: 10.1046/j.1537-2995.1977.17578014576.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

Review 1.  Plasmapheresis in paraproteinemia.

Authors:  H H Euler; N Schmitz; H Löffler
Journal:  Blut       Date:  1985-06

2.  Plasma lipid and apoprotein levels following plasmapheresis in a subject homozygous for familial hypercholesterolemia.

Authors:  S I Barr; B A Kottke; A A Pineda; S J Mao
Journal:  Experientia       Date:  1981-02-15

3.  Acidic polyamino acids inhibit human eosinophil granule major basic protein toxicity. Evidence of a functional role for ProMBP.

Authors:  R L Barker; R H Gundel; G J Gleich; J L Checkel; D A Loegering; L R Pease; K J Hamann
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

4.  Eosinophil ribonucleases and their cutaneous lesion-forming activity.

Authors:  Douglas A Plager; Mark D P Davis; Amy G Andrews; Michael J Coenen; Terry J George; Gerald J Gleich; Kristin M Leiferman
Journal:  J Immunol       Date:  2009-08-28       Impact factor: 5.422

5.  Purification of human eosinophil-derived neurotoxin.

Authors:  D T Durack; S J Ackerman; D A Loegering; G J Gleich
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

6.  Localization of eosinophil granule major basic protein in human basophils.

Authors:  S J Ackerman; G M Kephart; T M Habermann; P R Greipp; G J Gleich
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

Review 7.  Role of therapeutic apheresis and phlebotomy techniques in anaesthesia and critical care.

Authors:  Neeta Bose; Hitendra Kanzariya
Journal:  Indian J Anaesth       Date:  2014-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.